nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiabendazole—Leukopenia—Mitomycin—stomach cancer	0.00972	0.0111	CcSEcCtD
Thiabendazole—Feeling abnormal—Floxuridine—stomach cancer	0.00931	0.0106	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Floxuridine—stomach cancer	0.00923	0.0105	CcSEcCtD
Thiabendazole—Confusional state—Mitomycin—stomach cancer	0.00893	0.0102	CcSEcCtD
Thiabendazole—Abdominal pain—Floxuridine—stomach cancer	0.00893	0.0102	CcSEcCtD
Thiabendazole—Anorexia—Mitomycin—stomach cancer	0.00845	0.00964	CcSEcCtD
Thiabendazole—Hypersensitivity—Floxuridine—stomach cancer	0.00832	0.0095	CcSEcCtD
Thiabendazole—Asthenia—Floxuridine—stomach cancer	0.0081	0.00925	CcSEcCtD
Thiabendazole—Somnolence—Mitomycin—stomach cancer	0.00788	0.00899	CcSEcCtD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—PLAGL1—stomach cancer	0.0078	0.0628	CbGpPWpGaD
Thiabendazole—Diarrhoea—Floxuridine—stomach cancer	0.00773	0.00882	CcSEcCtD
Thiabendazole—Decreased appetite—Mitomycin—stomach cancer	0.0077	0.0088	CcSEcCtD
Thiabendazole—Fatigue—Mitomycin—stomach cancer	0.00764	0.00872	CcSEcCtD
Thiabendazole—Hepatocellular injury—Docetaxel—stomach cancer	0.00746	0.00851	CcSEcCtD
Thiabendazole—Coordination abnormal—Capecitabine—stomach cancer	0.00735	0.00839	CcSEcCtD
Thiabendazole—Feeling abnormal—Mitomycin—stomach cancer	0.0073	0.00834	CcSEcCtD
Thiabendazole—Vomiting—Floxuridine—stomach cancer	0.00718	0.0082	CcSEcCtD
Thiabendazole—Rash—Floxuridine—stomach cancer	0.00712	0.00813	CcSEcCtD
Thiabendazole—Dermatitis—Floxuridine—stomach cancer	0.00711	0.00812	CcSEcCtD
Thiabendazole—Headache—Floxuridine—stomach cancer	0.00707	0.00808	CcSEcCtD
Thiabendazole—Nausea—Floxuridine—stomach cancer	0.00671	0.00766	CcSEcCtD
Thiabendazole—Asthenia—Mitomycin—stomach cancer	0.00636	0.00726	CcSEcCtD
Thiabendazole—Diarrhoea—Mitomycin—stomach cancer	0.00606	0.00692	CcSEcCtD
Thiabendazole—Hepatic failure—Docetaxel—stomach cancer	0.00602	0.00688	CcSEcCtD
Thiabendazole—Liver injury—Epirubicin—stomach cancer	0.00598	0.00682	CcSEcCtD
Thiabendazole—Jaundice—Irinotecan—stomach cancer	0.00588	0.00672	CcSEcCtD
Thiabendazole—Dizziness—Mitomycin—stomach cancer	0.00586	0.00669	CcSEcCtD
Thiabendazole—Hepatic failure—Capecitabine—stomach cancer	0.00583	0.00666	CcSEcCtD
Thiabendazole—Vomiting—Mitomycin—stomach cancer	0.00563	0.00643	CcSEcCtD
Thiabendazole—Rash—Mitomycin—stomach cancer	0.00559	0.00638	CcSEcCtD
Thiabendazole—Dermatitis—Mitomycin—stomach cancer	0.00558	0.00637	CcSEcCtD
Thiabendazole—Headache—Mitomycin—stomach cancer	0.00555	0.00634	CcSEcCtD
Thiabendazole—Liver injury—Doxorubicin—stomach cancer	0.00553	0.00631	CcSEcCtD
Thiabendazole—Nausea—Mitomycin—stomach cancer	0.00526	0.00601	CcSEcCtD
Thiabendazole—Visual impairment—Irinotecan—stomach cancer	0.00522	0.00596	CcSEcCtD
Thiabendazole—Hypoaesthesia—Fluorouracil—stomach cancer	0.00516	0.00589	CcSEcCtD
Thiabendazole—Coordination abnormal—Epirubicin—stomach cancer	0.00512	0.00585	CcSEcCtD
Thiabendazole—CYP1A1—Benzo(a)pyrene metabolism—AKR1C3—stomach cancer	0.00512	0.0412	CbGpPWpGaD
Thiabendazole—Hepatocellular injury—Epirubicin—stomach cancer	0.00503	0.00574	CcSEcCtD
Thiabendazole—Flushing—Irinotecan—stomach cancer	0.00503	0.00574	CcSEcCtD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—PLAGL1—stomach cancer	0.00498	0.0401	CbGpPWpGaD
Thiabendazole—Chills—Irinotecan—stomach cancer	0.00486	0.00555	CcSEcCtD
Thiabendazole—Coordination abnormal—Doxorubicin—stomach cancer	0.00474	0.00541	CcSEcCtD
Thiabendazole—Hepatocellular injury—Doxorubicin—stomach cancer	0.00465	0.00531	CcSEcCtD
Thiabendazole—Lymphadenopathy—Methotrexate—stomach cancer	0.00457	0.00522	CcSEcCtD
Thiabendazole—Hepatic failure—Methotrexate—stomach cancer	0.00434	0.00496	CcSEcCtD
Thiabendazole—Lymphadenopathy—Epirubicin—stomach cancer	0.00428	0.00489	CcSEcCtD
Thiabendazole—Vision blurred—Fluorouracil—stomach cancer	0.00426	0.00486	CcSEcCtD
Thiabendazole—Leukopenia—Irinotecan—stomach cancer	0.00422	0.00482	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Docetaxel—stomach cancer	0.00414	0.00472	CcSEcCtD
Thiabendazole—Hyperglycaemia—Capecitabine—stomach cancer	0.00409	0.00466	CcSEcCtD
Thiabendazole—Jaundice—Docetaxel—stomach cancer	0.00407	0.00464	CcSEcCtD
Thiabendazole—Hepatic failure—Epirubicin—stomach cancer	0.00406	0.00464	CcSEcCtD
Thiabendazole—Leukopenia—Fluorouracil—stomach cancer	0.00404	0.00462	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Capecitabine—stomach cancer	0.004	0.00457	CcSEcCtD
Thiabendazole—Lymphadenopathy—Doxorubicin—stomach cancer	0.00396	0.00452	CcSEcCtD
Thiabendazole—Jaundice—Capecitabine—stomach cancer	0.00394	0.00449	CcSEcCtD
Thiabendazole—Convulsion—Fluorouracil—stomach cancer	0.00391	0.00447	CcSEcCtD
Thiabendazole—Confusional state—Irinotecan—stomach cancer	0.00388	0.00443	CcSEcCtD
Thiabendazole—Haematuria—Capecitabine—stomach cancer	0.00385	0.0044	CcSEcCtD
Thiabendazole—Anaphylactic shock—Irinotecan—stomach cancer	0.00385	0.00439	CcSEcCtD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—KLF6—stomach cancer	0.00381	0.0307	CbGpPWpGaD
Thiabendazole—Hepatic failure—Doxorubicin—stomach cancer	0.00376	0.00429	CcSEcCtD
Thiabendazole—Hypoaesthesia—Docetaxel—stomach cancer	0.00373	0.00425	CcSEcCtD
Thiabendazole—Confusional state—Fluorouracil—stomach cancer	0.00372	0.00424	CcSEcCtD
Thiabendazole—Anaphylactic shock—Fluorouracil—stomach cancer	0.00369	0.00421	CcSEcCtD
Thiabendazole—Anorexia—Irinotecan—stomach cancer	0.00367	0.00419	CcSEcCtD
Thiabendazole—Visual impairment—Docetaxel—stomach cancer	0.00361	0.00412	CcSEcCtD
Thiabendazole—Hypoaesthesia—Capecitabine—stomach cancer	0.00361	0.00412	CcSEcCtD
Thiabendazole—Hypotension—Irinotecan—stomach cancer	0.0036	0.00411	CcSEcCtD
Thiabendazole—Erythema multiforme—Docetaxel—stomach cancer	0.00354	0.00404	CcSEcCtD
Thiabendazole—Anorexia—Fluorouracil—stomach cancer	0.00351	0.00401	CcSEcCtD
Thiabendazole—Visual impairment—Capecitabine—stomach cancer	0.00349	0.00399	CcSEcCtD
Thiabendazole—Flushing—Docetaxel—stomach cancer	0.00347	0.00397	CcSEcCtD
Thiabendazole—Hypotension—Fluorouracil—stomach cancer	0.00344	0.00393	CcSEcCtD
Thiabendazole—Erythema multiforme—Capecitabine—stomach cancer	0.00343	0.00391	CcSEcCtD
Thiabendazole—Somnolence—Irinotecan—stomach cancer	0.00342	0.00391	CcSEcCtD
Thiabendazole—Dyspepsia—Irinotecan—stomach cancer	0.00339	0.00387	CcSEcCtD
Thiabendazole—Tinnitus—Capecitabine—stomach cancer	0.00338	0.00386	CcSEcCtD
Thiabendazole—Flushing—Capecitabine—stomach cancer	0.00336	0.00384	CcSEcCtD
Thiabendazole—Chills—Docetaxel—stomach cancer	0.00336	0.00384	CcSEcCtD
Thiabendazole—Decreased appetite—Irinotecan—stomach cancer	0.00335	0.00382	CcSEcCtD
Thiabendazole—CYP1A1—Fatty Acid Omega Oxidation—CYP2A6—stomach cancer	0.00332	0.0267	CbGpPWpGaD
Thiabendazole—Fatigue—Irinotecan—stomach cancer	0.00332	0.00379	CcSEcCtD
Thiabendazole—Somnolence—Fluorouracil—stomach cancer	0.00328	0.00374	CcSEcCtD
Thiabendazole—Chills—Capecitabine—stomach cancer	0.00325	0.00371	CcSEcCtD
Thiabendazole—Dyspepsia—Fluorouracil—stomach cancer	0.00324	0.0037	CcSEcCtD
Thiabendazole—Decreased appetite—Fluorouracil—stomach cancer	0.0032	0.00366	CcSEcCtD
Thiabendazole—Feeling abnormal—Irinotecan—stomach cancer	0.00317	0.00362	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Irinotecan—stomach cancer	0.00315	0.00359	CcSEcCtD
Thiabendazole—Abdominal pain—Irinotecan—stomach cancer	0.00304	0.00347	CcSEcCtD
Thiabendazole—Feeling abnormal—Fluorouracil—stomach cancer	0.00304	0.00347	CcSEcCtD
Thiabendazole—Drowsiness—Methotrexate—stomach cancer	0.00301	0.00343	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Methotrexate—stomach cancer	0.00298	0.0034	CcSEcCtD
Thiabendazole—Vision blurred—Capecitabine—stomach cancer	0.00297	0.0034	CcSEcCtD
Thiabendazole—Leukopenia—Docetaxel—stomach cancer	0.00292	0.00333	CcSEcCtD
Thiabendazole—Haematuria—Methotrexate—stomach cancer	0.00287	0.00327	CcSEcCtD
Thiabendazole—Hyperglycaemia—Epirubicin—stomach cancer	0.00285	0.00325	CcSEcCtD
Thiabendazole—Hypersensitivity—Irinotecan—stomach cancer	0.00284	0.00324	CcSEcCtD
Thiabendazole—Leukopenia—Capecitabine—stomach cancer	0.00282	0.00323	CcSEcCtD
Thiabendazole—Convulsion—Docetaxel—stomach cancer	0.00282	0.00322	CcSEcCtD
Thiabendazole—Drowsiness—Epirubicin—stomach cancer	0.00281	0.00321	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.00279	0.00318	CcSEcCtD
Thiabendazole—CYP1A1—Xenobiotics—CYP2A6—stomach cancer	0.00278	0.0224	CbGpPWpGaD
Thiabendazole—Asthenia—Irinotecan—stomach cancer	0.00276	0.00315	CcSEcCtD
Thiabendazole—Jaundice—Epirubicin—stomach cancer	0.00274	0.00313	CcSEcCtD
Thiabendazole—Hypersensitivity—Fluorouracil—stomach cancer	0.00272	0.0031	CcSEcCtD
Thiabendazole—Haematuria—Epirubicin—stomach cancer	0.00268	0.00306	CcSEcCtD
Thiabendazole—Confusional state—Docetaxel—stomach cancer	0.00268	0.00306	CcSEcCtD
Thiabendazole—CYP1A1—Tamoxifen metabolism—CYP2A6—stomach cancer	0.00267	0.0215	CbGpPWpGaD
Thiabendazole—Anaphylactic shock—Docetaxel—stomach cancer	0.00266	0.00304	CcSEcCtD
Thiabendazole—CYP1A2—Aflatoxin B1 metabolism—GSTM1—stomach cancer	0.00264	0.0213	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—SERPINB2—stomach cancer	0.00264	0.0213	CbGpPWpGaD
Thiabendazole—Hyperglycaemia—Doxorubicin—stomach cancer	0.00263	0.00301	CcSEcCtD
Thiabendazole—Diarrhoea—Irinotecan—stomach cancer	0.00263	0.00301	CcSEcCtD
Thiabendazole—Pruritus—Fluorouracil—stomach cancer	0.00261	0.00298	CcSEcCtD
Thiabendazole—Drowsiness—Doxorubicin—stomach cancer	0.0026	0.00297	CcSEcCtD
Thiabendazole—Visual impairment—Methotrexate—stomach cancer	0.0026	0.00297	CcSEcCtD
Thiabendazole—Confusional state—Capecitabine—stomach cancer	0.0026	0.00297	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.00258	0.00295	CcSEcCtD
Thiabendazole—Erythema multiforme—Methotrexate—stomach cancer	0.00255	0.00291	CcSEcCtD
Thiabendazole—Dizziness—Irinotecan—stomach cancer	0.00254	0.00291	CcSEcCtD
Thiabendazole—Jaundice—Doxorubicin—stomach cancer	0.00254	0.0029	CcSEcCtD
Thiabendazole—Anorexia—Docetaxel—stomach cancer	0.00254	0.0029	CcSEcCtD
Thiabendazole—Diarrhoea—Fluorouracil—stomach cancer	0.00252	0.00288	CcSEcCtD
Thiabendazole—Tinnitus—Methotrexate—stomach cancer	0.00252	0.00287	CcSEcCtD
Thiabendazole—Hypoaesthesia—Epirubicin—stomach cancer	0.00251	0.00287	CcSEcCtD
Thiabendazole—Hypotension—Docetaxel—stomach cancer	0.00249	0.00284	CcSEcCtD
Thiabendazole—Haematuria—Doxorubicin—stomach cancer	0.00248	0.00283	CcSEcCtD
Thiabendazole—Anorexia—Capecitabine—stomach cancer	0.00245	0.0028	CcSEcCtD
Thiabendazole—Vomiting—Irinotecan—stomach cancer	0.00245	0.00279	CcSEcCtD
Thiabendazole—Dizziness—Fluorouracil—stomach cancer	0.00244	0.00278	CcSEcCtD
Thiabendazole—Visual impairment—Epirubicin—stomach cancer	0.00243	0.00278	CcSEcCtD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—KLF6—stomach cancer	0.00243	0.0196	CbGpPWpGaD
Thiabendazole—Rash—Irinotecan—stomach cancer	0.00243	0.00277	CcSEcCtD
Thiabendazole—Dermatitis—Irinotecan—stomach cancer	0.00242	0.00277	CcSEcCtD
Thiabendazole—Chills—Methotrexate—stomach cancer	0.00242	0.00276	CcSEcCtD
Thiabendazole—Headache—Irinotecan—stomach cancer	0.00241	0.00275	CcSEcCtD
Thiabendazole—Hypotension—Capecitabine—stomach cancer	0.00241	0.00275	CcSEcCtD
Thiabendazole—Erythema multiforme—Epirubicin—stomach cancer	0.00239	0.00273	CcSEcCtD
Thiabendazole—Somnolence—Docetaxel—stomach cancer	0.00236	0.0027	CcSEcCtD
Thiabendazole—Tinnitus—Epirubicin—stomach cancer	0.00235	0.00269	CcSEcCtD
Thiabendazole—Flushing—Epirubicin—stomach cancer	0.00234	0.00268	CcSEcCtD
Thiabendazole—Vomiting—Fluorouracil—stomach cancer	0.00234	0.00268	CcSEcCtD
Thiabendazole—Dyspepsia—Docetaxel—stomach cancer	0.00234	0.00267	CcSEcCtD
Thiabendazole—Hypoaesthesia—Doxorubicin—stomach cancer	0.00233	0.00265	CcSEcCtD
Thiabendazole—Rash—Fluorouracil—stomach cancer	0.00232	0.00265	CcSEcCtD
Thiabendazole—Dermatitis—Fluorouracil—stomach cancer	0.00232	0.00265	CcSEcCtD
Thiabendazole—Decreased appetite—Docetaxel—stomach cancer	0.00231	0.00264	CcSEcCtD
Thiabendazole—Headache—Fluorouracil—stomach cancer	0.00231	0.00264	CcSEcCtD
Thiabendazole—Fatigue—Docetaxel—stomach cancer	0.00229	0.00262	CcSEcCtD
Thiabendazole—Nausea—Irinotecan—stomach cancer	0.00229	0.00261	CcSEcCtD
Thiabendazole—Dyspepsia—Capecitabine—stomach cancer	0.00227	0.00259	CcSEcCtD
Thiabendazole—Chills—Epirubicin—stomach cancer	0.00227	0.00259	CcSEcCtD
Thiabendazole—Visual impairment—Doxorubicin—stomach cancer	0.00225	0.00257	CcSEcCtD
Thiabendazole—Decreased appetite—Capecitabine—stomach cancer	0.00224	0.00256	CcSEcCtD
Thiabendazole—Fatigue—Capecitabine—stomach cancer	0.00222	0.00254	CcSEcCtD
Thiabendazole—Vision blurred—Methotrexate—stomach cancer	0.00221	0.00253	CcSEcCtD
Thiabendazole—Erythema multiforme—Doxorubicin—stomach cancer	0.00221	0.00252	CcSEcCtD
Thiabendazole—Feeling abnormal—Docetaxel—stomach cancer	0.00219	0.0025	CcSEcCtD
Thiabendazole—Nausea—Fluorouracil—stomach cancer	0.00219	0.0025	CcSEcCtD
Thiabendazole—CYP1A1—Tryptophan metabolism—ECHS1—stomach cancer	0.00219	0.0176	CbGpPWpGaD
Thiabendazole—Tinnitus—Doxorubicin—stomach cancer	0.00218	0.00249	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Docetaxel—stomach cancer	0.00218	0.00248	CcSEcCtD
Thiabendazole—Flushing—Doxorubicin—stomach cancer	0.00217	0.00248	CcSEcCtD
Thiabendazole—Feeling abnormal—Capecitabine—stomach cancer	0.00212	0.00242	CcSEcCtD
Thiabendazole—CYP1A2—Fatty Acid Omega Oxidation—CYP2A6—stomach cancer	0.00212	0.017	CbGpPWpGaD
Thiabendazole—Gastrointestinal pain—Capecitabine—stomach cancer	0.00211	0.0024	CcSEcCtD
Thiabendazole—Abdominal pain—Docetaxel—stomach cancer	0.0021	0.0024	CcSEcCtD
Thiabendazole—Leukopenia—Methotrexate—stomach cancer	0.0021	0.0024	CcSEcCtD
Thiabendazole—Chills—Doxorubicin—stomach cancer	0.0021	0.00239	CcSEcCtD
Thiabendazole—Vision blurred—Epirubicin—stomach cancer	0.00207	0.00237	CcSEcCtD
Thiabendazole—Abdominal pain—Capecitabine—stomach cancer	0.00204	0.00232	CcSEcCtD
Thiabendazole—Convulsion—Methotrexate—stomach cancer	0.00204	0.00232	CcSEcCtD
Thiabendazole—Leukopenia—Epirubicin—stomach cancer	0.00197	0.00225	CcSEcCtD
Thiabendazole—Hypersensitivity—Docetaxel—stomach cancer	0.00196	0.00224	CcSEcCtD
Thiabendazole—CYP1A1—Estrogen metabolism—GSTM1—stomach cancer	0.00195	0.0157	CbGpPWpGaD
Thiabendazole—Confusional state—Methotrexate—stomach cancer	0.00193	0.00221	CcSEcCtD
Thiabendazole—Anaphylactic shock—Methotrexate—stomach cancer	0.00192	0.00219	CcSEcCtD
Thiabendazole—Vision blurred—Doxorubicin—stomach cancer	0.00192	0.00219	CcSEcCtD
Thiabendazole—Asthenia—Docetaxel—stomach cancer	0.00191	0.00218	CcSEcCtD
Thiabendazole—Convulsion—Epirubicin—stomach cancer	0.0019	0.00217	CcSEcCtD
Thiabendazole—Hypersensitivity—Capecitabine—stomach cancer	0.0019	0.00217	CcSEcCtD
Thiabendazole—Pruritus—Docetaxel—stomach cancer	0.00188	0.00215	CcSEcCtD
Thiabendazole—CYP1A1—Melatonin metabolism and effects—ADRB1—stomach cancer	0.00186	0.015	CbGpPWpGaD
Thiabendazole—Asthenia—Capecitabine—stomach cancer	0.00185	0.00211	CcSEcCtD
Thiabendazole—Anorexia—Methotrexate—stomach cancer	0.00183	0.00209	CcSEcCtD
Thiabendazole—Pruritus—Capecitabine—stomach cancer	0.00182	0.00208	CcSEcCtD
Thiabendazole—Leukopenia—Doxorubicin—stomach cancer	0.00182	0.00208	CcSEcCtD
Thiabendazole—Diarrhoea—Docetaxel—stomach cancer	0.00182	0.00208	CcSEcCtD
Thiabendazole—Confusional state—Epirubicin—stomach cancer	0.00181	0.00207	CcSEcCtD
Thiabendazole—Anaphylactic shock—Epirubicin—stomach cancer	0.00179	0.00205	CcSEcCtD
Thiabendazole—Hypotension—Methotrexate—stomach cancer	0.00179	0.00205	CcSEcCtD
Thiabendazole—CYP1A2—Xenobiotics—CYP2A6—stomach cancer	0.00177	0.0143	CbGpPWpGaD
Thiabendazole—Convulsion—Doxorubicin—stomach cancer	0.00176	0.00201	CcSEcCtD
Thiabendazole—Diarrhoea—Capecitabine—stomach cancer	0.00176	0.00201	CcSEcCtD
Thiabendazole—Dizziness—Docetaxel—stomach cancer	0.00176	0.00201	CcSEcCtD
Thiabendazole—Anorexia—Epirubicin—stomach cancer	0.00171	0.00195	CcSEcCtD
Thiabendazole—Somnolence—Methotrexate—stomach cancer	0.0017	0.00195	CcSEcCtD
Thiabendazole—Dizziness—Capecitabine—stomach cancer	0.0017	0.00194	CcSEcCtD
Thiabendazole—CYP1A2—Tamoxifen metabolism—CYP2A6—stomach cancer	0.0017	0.0137	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—AHR—stomach cancer	0.0017	0.0137	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—AHR—stomach cancer	0.0017	0.0137	CbGpPWpGaD
Thiabendazole—Vomiting—Docetaxel—stomach cancer	0.00169	0.00193	CcSEcCtD
Thiabendazole—Dyspepsia—Methotrexate—stomach cancer	0.00169	0.00193	CcSEcCtD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SERPINB2—stomach cancer	0.00168	0.0136	CbGpPWpGaD
Thiabendazole—Rash—Docetaxel—stomach cancer	0.00168	0.00192	CcSEcCtD
Thiabendazole—Hypotension—Epirubicin—stomach cancer	0.00168	0.00191	CcSEcCtD
Thiabendazole—Dermatitis—Docetaxel—stomach cancer	0.00168	0.00191	CcSEcCtD
Thiabendazole—Confusional state—Doxorubicin—stomach cancer	0.00167	0.00191	CcSEcCtD
Thiabendazole—Decreased appetite—Methotrexate—stomach cancer	0.00167	0.0019	CcSEcCtD
Thiabendazole—Headache—Docetaxel—stomach cancer	0.00167	0.0019	CcSEcCtD
Thiabendazole—Anaphylactic shock—Doxorubicin—stomach cancer	0.00166	0.0019	CcSEcCtD
Thiabendazole—Fatigue—Methotrexate—stomach cancer	0.00165	0.00189	CcSEcCtD
Thiabendazole—Vomiting—Capecitabine—stomach cancer	0.00164	0.00187	CcSEcCtD
Thiabendazole—Rash—Capecitabine—stomach cancer	0.00162	0.00185	CcSEcCtD
Thiabendazole—Dermatitis—Capecitabine—stomach cancer	0.00162	0.00185	CcSEcCtD
Thiabendazole—Headache—Capecitabine—stomach cancer	0.00161	0.00184	CcSEcCtD
Thiabendazole—Somnolence—Epirubicin—stomach cancer	0.0016	0.00182	CcSEcCtD
Thiabendazole—Anorexia—Doxorubicin—stomach cancer	0.00158	0.00181	CcSEcCtD
Thiabendazole—Nausea—Docetaxel—stomach cancer	0.00158	0.0018	CcSEcCtD
Thiabendazole—Feeling abnormal—Methotrexate—stomach cancer	0.00158	0.0018	CcSEcCtD
Thiabendazole—Dyspepsia—Epirubicin—stomach cancer	0.00158	0.0018	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Methotrexate—stomach cancer	0.00157	0.00179	CcSEcCtD
Thiabendazole—Decreased appetite—Epirubicin—stomach cancer	0.00156	0.00178	CcSEcCtD
Thiabendazole—CYP1A1—Arachidonic acid metabolism—ALOX5—stomach cancer	0.00155	0.0125	CbGpPWpGaD
Thiabendazole—Hypotension—Doxorubicin—stomach cancer	0.00155	0.00177	CcSEcCtD
Thiabendazole—Fatigue—Epirubicin—stomach cancer	0.00155	0.00177	CcSEcCtD
Thiabendazole—Nausea—Capecitabine—stomach cancer	0.00153	0.00175	CcSEcCtD
Thiabendazole—Abdominal pain—Methotrexate—stomach cancer	0.00152	0.00173	CcSEcCtD
Thiabendazole—Feeling abnormal—Epirubicin—stomach cancer	0.00148	0.00169	CcSEcCtD
Thiabendazole—Somnolence—Doxorubicin—stomach cancer	0.00148	0.00169	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Epirubicin—stomach cancer	0.00147	0.00168	CcSEcCtD
Thiabendazole—Dyspepsia—Doxorubicin—stomach cancer	0.00146	0.00167	CcSEcCtD
Thiabendazole—Decreased appetite—Doxorubicin—stomach cancer	0.00144	0.00165	CcSEcCtD
Thiabendazole—Fatigue—Doxorubicin—stomach cancer	0.00143	0.00163	CcSEcCtD
Thiabendazole—Abdominal pain—Epirubicin—stomach cancer	0.00142	0.00162	CcSEcCtD
Thiabendazole—Hypersensitivity—Methotrexate—stomach cancer	0.00141	0.00161	CcSEcCtD
Thiabendazole—CYP1A2—Tryptophan metabolism—ECHS1—stomach cancer	0.0014	0.0112	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidative Stress—HMOX1—stomach cancer	0.00139	0.0112	CbGpPWpGaD
Thiabendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—stomach cancer	0.00138	0.0111	CbGpPWpGaD
Thiabendazole—Asthenia—Methotrexate—stomach cancer	0.00138	0.00157	CcSEcCtD
Thiabendazole—Feeling abnormal—Doxorubicin—stomach cancer	0.00137	0.00156	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Doxorubicin—stomach cancer	0.00136	0.00155	CcSEcCtD
Thiabendazole—Pruritus—Methotrexate—stomach cancer	0.00136	0.00155	CcSEcCtD
Thiabendazole—CYP1A1—PPARA activates gene expression—PLIN2—stomach cancer	0.00135	0.0109	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PLIN2—stomach cancer	0.00132	0.0107	CbGpPWpGaD
Thiabendazole—Hypersensitivity—Epirubicin—stomach cancer	0.00132	0.00151	CcSEcCtD
Thiabendazole—Abdominal pain—Doxorubicin—stomach cancer	0.00131	0.0015	CcSEcCtD
Thiabendazole—Diarrhoea—Methotrexate—stomach cancer	0.00131	0.0015	CcSEcCtD
Thiabendazole—CYP1A1—Oxidative Stress—SOD2—stomach cancer	0.0013	0.0105	CbGpPWpGaD
Thiabendazole—CYP1A1—Arachidonic acid metabolism—AKR1C3—stomach cancer	0.0013	0.0104	CbGpPWpGaD
Thiabendazole—Asthenia—Epirubicin—stomach cancer	0.00129	0.00147	CcSEcCtD
Thiabendazole—CYP1A1—Estrogen Receptor Pathway—JUN—stomach cancer	0.00128	0.0103	CbGpPWpGaD
Thiabendazole—Pruritus—Epirubicin—stomach cancer	0.00127	0.00145	CcSEcCtD
Thiabendazole—Dizziness—Methotrexate—stomach cancer	0.00127	0.00145	CcSEcCtD
Thiabendazole—CYP1A2—Estrogen metabolism—GSTM1—stomach cancer	0.00124	0.00999	CbGpPWpGaD
Thiabendazole—Diarrhoea—Epirubicin—stomach cancer	0.00123	0.0014	CcSEcCtD
Thiabendazole—Hypersensitivity—Doxorubicin—stomach cancer	0.00122	0.0014	CcSEcCtD
Thiabendazole—Vomiting—Methotrexate—stomach cancer	0.00122	0.00139	CcSEcCtD
Thiabendazole—Rash—Methotrexate—stomach cancer	0.00121	0.00138	CcSEcCtD
Thiabendazole—Dermatitis—Methotrexate—stomach cancer	0.00121	0.00138	CcSEcCtD
Thiabendazole—Headache—Methotrexate—stomach cancer	0.0012	0.00137	CcSEcCtD
Thiabendazole—Asthenia—Doxorubicin—stomach cancer	0.00119	0.00136	CcSEcCtD
Thiabendazole—Dizziness—Epirubicin—stomach cancer	0.00119	0.00135	CcSEcCtD
Thiabendazole—CYP1A2—Melatonin metabolism and effects—ADRB1—stomach cancer	0.00118	0.00954	CbGpPWpGaD
Thiabendazole—Pruritus—Doxorubicin—stomach cancer	0.00117	0.00134	CcSEcCtD
Thiabendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2A6—stomach cancer	0.00115	0.00928	CbGpPWpGaD
Thiabendazole—Vomiting—Epirubicin—stomach cancer	0.00114	0.0013	CcSEcCtD
Thiabendazole—Nausea—Methotrexate—stomach cancer	0.00114	0.0013	CcSEcCtD
Thiabendazole—CYP1A1—Oxidation by Cytochrome P450—CYP2A6—stomach cancer	0.00114	0.00916	CbGpPWpGaD
Thiabendazole—Diarrhoea—Doxorubicin—stomach cancer	0.00114	0.0013	CcSEcCtD
Thiabendazole—Rash—Epirubicin—stomach cancer	0.00113	0.00129	CcSEcCtD
Thiabendazole—Dermatitis—Epirubicin—stomach cancer	0.00113	0.00129	CcSEcCtD
Thiabendazole—Headache—Epirubicin—stomach cancer	0.00112	0.00128	CcSEcCtD
Thiabendazole—CYP1A1—Estrogen Receptor Pathway—STAT3—stomach cancer	0.00111	0.00894	CbGpPWpGaD
Thiabendazole—Dizziness—Doxorubicin—stomach cancer	0.0011	0.00125	CcSEcCtD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—AHR—stomach cancer	0.00109	0.00874	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—AHR—stomach cancer	0.00109	0.00874	CbGpPWpGaD
Thiabendazole—Nausea—Epirubicin—stomach cancer	0.00107	0.00122	CcSEcCtD
Thiabendazole—Vomiting—Doxorubicin—stomach cancer	0.00106	0.00121	CcSEcCtD
Thiabendazole—Rash—Doxorubicin—stomach cancer	0.00105	0.0012	CcSEcCtD
Thiabendazole—Dermatitis—Doxorubicin—stomach cancer	0.00105	0.00119	CcSEcCtD
Thiabendazole—Headache—Doxorubicin—stomach cancer	0.00104	0.00119	CcSEcCtD
Thiabendazole—CYP1A1—PPARA activates gene expression—FADS1—stomach cancer	0.00102	0.00825	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—FADS1—stomach cancer	0.001	0.00807	CbGpPWpGaD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—ALOX5—stomach cancer	0.000989	0.00797	CbGpPWpGaD
Thiabendazole—Nausea—Doxorubicin—stomach cancer	0.000986	0.00113	CcSEcCtD
Thiabendazole—CYP1A1—PPARA activates gene expression—SREBF2—stomach cancer	0.000959	0.00772	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—RORA—stomach cancer	0.000948	0.00763	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—SREBF2—stomach cancer	0.000939	0.00756	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	0.000935	0.00753	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RORA—stomach cancer	0.000928	0.00747	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PLIN2—stomach cancer	0.000912	0.00734	CbGpPWpGaD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—AKR1C3—stomach cancer	0.000828	0.00666	CbGpPWpGaD
Thiabendazole—CYP1A2—Estrogen Receptor Pathway—JUN—stomach cancer	0.000819	0.00659	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A6—stomach cancer	0.000735	0.00592	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ECHS1—stomach cancer	0.000735	0.00592	CbGpPWpGaD
Thiabendazole—CYP1A2—Oxidation by Cytochrome P450—CYP2A6—stomach cancer	0.000726	0.00584	CbGpPWpGaD
Thiabendazole—CYP1A2—Estrogen Receptor Pathway—STAT3—stomach cancer	0.000708	0.0057	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—FADS1—stomach cancer	0.000691	0.00556	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—SREBF2—stomach cancer	0.000647	0.00521	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—RORA—stomach cancer	0.000639	0.00515	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	0.000596	0.0048	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase II conjugation—GSTT1—stomach cancer	0.000548	0.00441	CbGpPWpGaD
Thiabendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	0.000535	0.00431	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—stomach cancer	0.000518	0.00417	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—GSTT1—stomach cancer	0.000502	0.00404	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—CYP2A6—stomach cancer	0.000497	0.004	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—stomach cancer	0.000491	0.00395	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—stomach cancer	0.000491	0.00395	CbGpPWpGaD
Thiabendazole—CYP1A1—Arachidonic acid metabolism—PTGS2—stomach cancer	0.000485	0.0039	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—stomach cancer	0.000482	0.00388	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—AKR1C3—stomach cancer	0.000476	0.00384	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—stomach cancer	0.000467	0.00376	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—stomach cancer	0.000453	0.00365	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	0.000433	0.00349	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—stomach cancer	0.000408	0.00329	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase II conjugation—GSTP1—stomach cancer	0.00038	0.00306	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—stomach cancer	0.000376	0.00302	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—APOA1—stomach cancer	0.000372	0.003	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—stomach cancer	0.000367	0.00296	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—stomach cancer	0.000367	0.00296	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—stomach cancer	0.000367	0.00296	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—APOA1—stomach cancer	0.000364	0.00293	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	0.000363	0.00292	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—stomach cancer	0.00035	0.00282	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—stomach cancer	0.00035	0.00282	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase II conjugation—GSTM1—stomach cancer	0.000349	0.00281	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—GSTP1—stomach cancer	0.000348	0.0028	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—stomach cancer	0.000347	0.00279	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—GSTP1—stomach cancer	0.000343	0.00276	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—stomach cancer	0.00033	0.00266	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—PPARG—stomach cancer	0.000328	0.00264	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—stomach cancer	0.000321	0.00258	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—GSTT1—stomach cancer	0.00032	0.00258	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—GSTM1—stomach cancer	0.00032	0.00258	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP2A6—stomach cancer	0.000317	0.00255	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—GSTM1—stomach cancer	0.000316	0.00254	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—stomach cancer	0.000313	0.00252	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—stomach cancer	0.000313	0.00252	CbGpPWpGaD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—PTGS2—stomach cancer	0.000309	0.00249	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—stomach cancer	0.000307	0.00247	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—AKR1C3—stomach cancer	0.000304	0.00245	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ACAD8—stomach cancer	0.000299	0.00241	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—stomach cancer	0.000298	0.0024	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—stomach cancer	0.000295	0.00237	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	0.000293	0.00236	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—stomach cancer	0.000289	0.00232	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	0.000276	0.00222	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	0.000275	0.00221	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GMPR2—stomach cancer	0.000267	0.00215	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—stomach cancer	0.00026	0.0021	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	0.000258	0.00207	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—RORA—stomach cancer	0.000255	0.00205	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—APOA1—stomach cancer	0.000251	0.00202	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—IDH3B—stomach cancer	0.000244	0.00196	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SUCLG1—stomach cancer	0.000244	0.00196	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—stomach cancer	0.000239	0.00193	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—stomach cancer	0.000234	0.00189	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—stomach cancer	0.000234	0.00189	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—stomach cancer	0.000234	0.00189	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	0.000231	0.00186	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NDUFS1—stomach cancer	0.000227	0.00183	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NDUFV1—stomach cancer	0.000227	0.00183	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—stomach cancer	0.000223	0.0018	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—stomach cancer	0.000223	0.0018	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—GSTP1—stomach cancer	0.000222	0.00179	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	0.000222	0.00179	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—stomach cancer	0.000221	0.00178	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—stomach cancer	0.000221	0.00178	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—GSTP1—stomach cancer	0.000219	0.00176	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—GSTM1—stomach cancer	0.000204	0.00164	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PGLS—stomach cancer	0.000202	0.00163	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—BLVRB—stomach cancer	0.000202	0.00163	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—GSTM1—stomach cancer	0.000201	0.00162	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PPAP2A—stomach cancer	0.000193	0.00155	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ACAD8—stomach cancer	0.000191	0.00154	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—stomach cancer	0.000188	0.00151	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	0.000187	0.0015	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	0.000186	0.00149	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	0.000175	0.00141	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CKB—stomach cancer	0.000172	0.00138	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CA1—stomach cancer	0.000172	0.00138	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—FBP1—stomach cancer	0.000172	0.00138	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NDUFA2—stomach cancer	0.000172	0.00138	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GMPR2—stomach cancer	0.00017	0.00137	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	0.000164	0.00132	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—RORA—stomach cancer	0.000162	0.00131	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PLIN2—stomach cancer	0.000162	0.0013	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CA2—stomach cancer	0.000157	0.00127	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SUCLG1—stomach cancer	0.000156	0.00125	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—IDH3B—stomach cancer	0.000156	0.00125	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NT5E—stomach cancer	0.000153	0.00123	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PGAM1—stomach cancer	0.000153	0.00123	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ALDH7A1—stomach cancer	0.000146	0.00118	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PLCE1—stomach cancer	0.000146	0.00118	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NDUFV1—stomach cancer	0.000145	0.00116	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NDUFS1—stomach cancer	0.000145	0.00116	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	0.000141	0.00114	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—UMPS—stomach cancer	0.00014	0.00113	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PDHA1—stomach cancer	0.00013	0.00105	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ECHS1—stomach cancer	0.00013	0.00105	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PGLS—stomach cancer	0.000129	0.00104	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—BLVRB—stomach cancer	0.000129	0.00104	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PPAP2A—stomach cancer	0.000123	0.00099	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—TYMP—stomach cancer	0.000123	0.000986	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—FADS1—stomach cancer	0.000123	0.000986	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	0.000118	0.000952	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SREBF2—stomach cancer	0.000115	0.000924	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—RORA—stomach cancer	0.000113	0.000913	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—FBP1—stomach cancer	0.00011	0.000883	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NDUFA2—stomach cancer	0.00011	0.000883	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CKB—stomach cancer	0.00011	0.000883	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CA1—stomach cancer	0.00011	0.000883	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ALDOB—stomach cancer	0.000106	0.000855	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PLIN2—stomach cancer	0.000103	0.00083	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CA2—stomach cancer	0.0001	0.000807	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	0.0001	0.000806	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	9.99e-05	0.000805	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ALOX5—stomach cancer	9.88e-05	0.000795	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PGAM1—stomach cancer	9.77e-05	0.000787	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NT5E—stomach cancer	9.77e-05	0.000787	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—DPYD—stomach cancer	9.72e-05	0.000782	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PLCE1—stomach cancer	9.32e-05	0.000751	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ALDH7A1—stomach cancer	9.32e-05	0.000751	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—UMPS—stomach cancer	8.94e-05	0.00072	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	8.81e-05	0.000709	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTT1—stomach cancer	8.59e-05	0.000692	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP2A6—stomach cancer	8.49e-05	0.000684	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PDHA1—stomach cancer	8.31e-05	0.000669	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ECHS1—stomach cancer	8.31e-05	0.000669	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—AKR1C3—stomach cancer	8.26e-05	0.000665	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ENO1—stomach cancer	8.05e-05	0.000648	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	7.92e-05	0.000637	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—FADS1—stomach cancer	7.81e-05	0.000629	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—TYMP—stomach cancer	7.81e-05	0.000629	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SREBF2—stomach cancer	7.32e-05	0.000589	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—RORA—stomach cancer	7.23e-05	0.000582	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CD44—stomach cancer	7.14e-05	0.000575	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	6.93e-05	0.000558	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ALDOB—stomach cancer	6.77e-05	0.000545	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	6.39e-05	0.000514	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	6.37e-05	0.000513	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ALOX5—stomach cancer	6.3e-05	0.000507	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—DPYD—stomach cancer	6.2e-05	0.000499	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PPP2R1A—stomach cancer	6.07e-05	0.000489	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTP1—stomach cancer	5.96e-05	0.000479	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HMOX1—stomach cancer	5.87e-05	0.000473	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	5.62e-05	0.000452	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—TYMS—stomach cancer	5.54e-05	0.000446	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTT1—stomach cancer	5.48e-05	0.000441	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTM1—stomach cancer	5.47e-05	0.000441	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP2A6—stomach cancer	5.42e-05	0.000436	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—AKR1C3—stomach cancer	5.27e-05	0.000424	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ERCC2—stomach cancer	5.15e-05	0.000414	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ENO1—stomach cancer	5.13e-05	0.000413	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	5.05e-05	0.000406	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—MTHFR—stomach cancer	4.84e-05	0.000389	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CD44—stomach cancer	4.55e-05	0.000367	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CAV1—stomach cancer	4.46e-05	0.000359	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—APOA1—stomach cancer	4.45e-05	0.000358	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.42e-05	0.000356	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.26e-05	0.000343	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PPARG—stomach cancer	3.92e-05	0.000316	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PPP2R1A—stomach cancer	3.87e-05	0.000312	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTP1—stomach cancer	3.8e-05	0.000306	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HMOX1—stomach cancer	3.74e-05	0.000301	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—TYMS—stomach cancer	3.53e-05	0.000284	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ALB—stomach cancer	3.53e-05	0.000284	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTM1—stomach cancer	3.49e-05	0.000281	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NOS3—stomach cancer	3.37e-05	0.000272	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ERCC2—stomach cancer	3.28e-05	0.000264	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PTGS2—stomach cancer	3.09e-05	0.000248	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—MTHFR—stomach cancer	3.08e-05	0.000248	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CAV1—stomach cancer	2.84e-05	0.000229	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—APOA1—stomach cancer	2.84e-05	0.000228	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.72e-05	0.000219	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PPARG—stomach cancer	2.5e-05	0.000201	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ALB—stomach cancer	2.25e-05	0.000181	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NOS3—stomach cancer	2.15e-05	0.000173	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PTGS2—stomach cancer	1.97e-05	0.000158	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PIK3CA—stomach cancer	1.9e-05	0.000153	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PIK3CA—stomach cancer	1.21e-05	9.74e-05	CbGpPWpGaD
